A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/16 (2006.01) A61K 31/277 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/4184 (2006.01) A61K 31/439 (2006.01) A61K 31/44 (2006.01) A61K 31/4409 (2006.01) A61K 31/47 (2006.01) A61K 31/4706 (2006.01) A61K 31/5375 (2006.01) A61K 31/655 (2006.01)
Patent
CA 2677230
The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor.
L'invention concerne des procédés d'amélioration d'une sécrétion d'insuline, d'une sécrétion de GLP-1, et d'une sensibilité à l'insuline, des procédés d'augmentation de l'expression du gène d'insuline, des procédés de diminution de sécrétion et de vidange gastrique, et de diminution de sécrétion de glucagons, des procédés d'inhibition de prise alimentaire, et des procédés de traitement du diabète sucré, du syndrome d'insuline-résistance, de l'hyperglycémie et de l'obésité, comprenant l'administration à un sujet d'une quantité efficace d'un inhibiteur de TRPM5.
Bryant Robert
Buber M. N. Tulu
Cerne Rok
Lee S. Paul
Morgan Gillian
Gowling Lafleur Henderson Llp
Redpoint Bio Corporation
LandOfFree
Use of a trpm5 inhibitor to regulate insulin and glp-1 release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a trpm5 inhibitor to regulate insulin and glp-1 release, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a trpm5 inhibitor to regulate insulin and glp-1 release will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1591423